Nuvectis Pharma (NVCT) Analyst & Key Data

Analyst Consensus

Buy4 analysts

Buy

Updated Sep 12, 2026

Total Analysts4

Buy

3

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$23.99

Median Target+30.26%

$31.25

Potential upside vs current price

DCF Value-95.09%

$1.18

Potential downside vs current price

Current Stock Price

$23.99

Median Target+30.26%

$31.25

Potential upside vs current price

DCF Value-95.09%

$1.18

Potential downside vs current price

Analyst Consensus

Buy4 analysts

Buy

Updated Sep 12, 2026

Total Analysts4

Buy

3

Ratings

Updated Sep 12, 2026

Overall Rating

C-

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$23.99

Median Target+30.26%

$31.25

Potential upside vs current price

DCF Value-95.09%

$1.18

Potential downside vs current price

Current Stock Price

$23.99

Median Target+30.26%

$31.25

Potential upside vs current price

DCF Value-95.09%

$1.18

Potential downside vs current price

Nuvectis Pharma, Inc.